Abstract:The trans-acting activator of transcription (TAT) peptide, which is derived from human immunodeficiency virus-1 (HIV-1), has been widely used as an effective nanocarrier to transport extracellular substances into cells. However, the underlying translocation mechanism of TAT peptide across cell membranes still remains controversial. Besides, the molecular process of TAT peptide facilitating the transport of extracellular substances into cells is largely unknown. In this study, we explore the interactions of TAT peptides and their conjugated gold nanoparticles with lipid membranes by coarse-grained molecular dynamics simulations. It is found that the TAT peptides can hardly penetrate through the membrane at low peptide concentrations; after the concentration increases to a threshold value, they can cross the membrane through an induced nanopore due to the transmembrane electrostatic potential difference. The translocation of TAT peptides is mainly caused by the overall structural changes of membranes. Furthermore, we demonstrate that the translocation of gold nanoparticles (AuNPs) across the membrane is significantly affected by the number of grafted TAT peptides on the particle surface. The transmembrane efficiency of AuNPs may even be reduced when a small number of peptides modify them; whereas, when the number of grafted peptides increases to a certain value, the TAT-AuNP complex can translocate across the membrane in a pore-mediated way. Based on our findings, an effective strategy has been proposed to enhance the delivery efficiency of AuNPs. The present study can improve our understanding of the interactions between TAT peptides and cell membranes; it may also give some insightful suggestions on the design and development of nanocarriers with high efficiency for the delivery of nanoparticles and drugs.

Intracellular Transduction and Potential of Tat PTD and Its Analogs: from Basic Drug Delivery Mechanism to Application

Intracellular traffic and fate of protein transduction domains HIV-1 TAT peptide and octaarginine. Implications for their utilization as drug delivery vectors

Molecular Mechanism of HIV-1 TAT Peptide and Its Conjugated Gold Nanoparticles Translocating Across Lipid Membranes

Protein transduction technology: a novel therapeutic perspective

TAT Protein Transduction Domain Mediates Transmembrane Delivery of EGFP into Tissue Cells of Mice in Vivo

Can the Cellular Internalization of Cargo Proteins Be Enhanced by Fusing a Tat Peptide in the Center of Proteins? A Fluorescence Study

Improvement of Cellular Adenovirus Uptake with TAT Peptide is Cell-type Dependent

Possible Mecanism of Transmembrane of TAT-PTD Fusion Protein

Spotlight on HIV-derived TAT peptide as a molecular shuttle in drug delivery

[PTD Mediated Protein Transduction Technology and Its Application in Medical Field].

TAT-Mediated Transmembrane Delivery of Fusion Protein into Different Organs and Skin in Mice

A Novel Type of Ptd, Common Helix-Loop-Helix Motif, Could Efficiently Mediate Protein Transduction into Mammalian Cells

Integrin Facilitates the Internalization of TAT Peptide Conjugated to RGD Motif in Model Lipid Membranes

HIV-1 TAT-mediated protein transduction and subcellular localization using novel expression vectors.

Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis

TAT Protein Transduction Domain Mediates Transmembrane Delivery of BCR/ABL Fusion Protein into Tissue Cells of Mice in Vivo

A Novel Recombinant Protein Tat-Gfp-Kdel with Dual-Function of Penetrating Cell Membrane and Locating at Endoplasm Reticulum

Genetically Modified Adenoviral Vector with the Protein Transduction Domain of Tat Improves Gene Transfer to CAR-deficient Cells

Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers.

Heterogenic Bcl-Xs Fused with Tat Basic Domain Can Induce Programmed Cell Death after Transient Incubation

Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding